FMP
Feb 8, 2024 7:20 PM - Davit Kirakosyan(Last modified: Feb 9, 2024 1:15 AM)
Image credit: FMP
CVS Health (NYSE:CVS) disclosed its fourth-quarter financial results and revised its earnings forecast for 2024 downwards.
In the fourth quarter of 2023, CVS Health announced an earnings per share (EPS) of $2.12, surpassing the analysts' consensus of $1.98. The company's revenue for the quarter was $93.81 billion, exceeding expectations of $90.25 billion.
Revenue from health services reached $49.15 billion, outperforming the anticipated $45.96 billion by analysts.
Looking into the full fiscal year of 2024, CVS Health adjusted its EPS forecast to a minimum of $8.30, a decrease from the previously projected $8.50. This adjustment comes in below the analyst consensus of $8.47.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 16, 2024 8:06 PM - Gordon Thompson
On Thursday, May 16, 2024, Deutsche Bank upgraded its rating on NASDAQ:ASTS to Buy, maintaining a hold position. At the time of the announcement, ASTS was trading at $4.03. This decision was accompanied by an increase in the price target for AST SpaceMobile, raised to $22 from $19, as detailed in a ...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...